Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Airflow Limitation”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Not applicableLooking for participantsNCT03263130
What this trial is testing

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Who this might be right for
COPD, Emphysema, Asthma COPD OverlapEmphysema
Gelb, Arthur F., M.D. 60
Post-approval studies (Phase 4)Active Not RecruitingNCT02797275
What this trial is testing

Secondhand Smoke Respiratory Health Study

Who this might be right for
Secondhand SmokeAir TrappingTobacco+3 more
University of California, San Francisco 107
Large-scale testing (Phase 3)Looking for participantsNCT04204252
What this trial is testing

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Kamada, Ltd. 220
Large-scale testing (Phase 3)Study completedNCT01727141
What this trial is testing

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 1,042
Not applicableNot Yet RecruitingNCT07315958
What this trial is testing

A Multinational, Multicenter, Observational, Prospective Cohort Study for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Cardiology Clinics

Who this might be right for
Respiratory (Chronic Obstructive Pulmonary Disease)
AstraZeneca 1,000
Large-scale testing (Phase 3)Study completedNCT01712516
What this trial is testing

A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 1,001
Large-scale testing (Phase 3)Study completedNCT02487498
What this trial is testing

Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 355
Post-approval studies (Phase 4)Looking for participantsNCT01225913
What this trial is testing

Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Who this might be right for
Asthma
Gelb, Arthur F., M.D. 50
Large-scale testing (Phase 3)Study completedNCT01610037
What this trial is testing

Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 1,215
Large-scale testing (Phase 3)Study completedNCT01697696
What this trial is testing

Long Term Safety Study of NVA237 vs QAB149 in COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 511
Not applicableStudy completedNCT02600221
What this trial is testing

A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China

Who this might be right for
Asthma-COPD Overlap Syndrome
AstraZeneca 2,016
Not applicableUnknownNCT00865293
What this trial is testing

Expiratory Airflow Limitation in Subjects With Obesity

Who this might be right for
Obesity
Medical Center Alkmaar 30
Large-scale testing (Phase 3)Study completedNCT02487446
What this trial is testing

Efficacy and Safety Study of QVA149 in COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 357
Post-approval studies (Phase 4)Study completedNCT01010178
What this trial is testing

Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?

Who this might be right for
Chronic Obstructive Pulmonary Disease
Baqiyatallah Medical Sciences University 64
Testing effectiveness (Phase 2)Study completedNCT02130193
What this trial is testing

Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 102
Not applicableStudy completedNCT01695265
What this trial is testing

Feel Breathe, Restriction Device Ventilatory Nasal (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of Cadiz 20
Post-approval studies (Phase 4)UnknownNCT04509661
What this trial is testing

Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation

Who this might be right for
Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China 200
Not applicableLooking for participantsNCT06612294
What this trial is testing

Asthma Symptom Perception Study

Who this might be right for
Asthma
Icahn School of Medicine at Mount Sinai 300
Not applicableStudy completedNCT01485159
What this trial is testing

Airflow Limitation in Cardiac Diseases in Europe

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 3,000
Not applicableUnknownNCT03592212
What this trial is testing

Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma

Who this might be right for
Asthma
Assistance Publique - Hôpitaux de Paris 99
Load More Results